Abacus Fcf Advisors LLC’s Johnson & Johnson Position
Does Abacus Fcf Advisors LLC own Johnson & Johnson (JNJ)? Not currently — the last reported position was 106.2K shares worth $18M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$18M
Q1 2025
Shares
106.2K
% of Portfolio
+2.77%
Quarters Held
16
position exited
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 106.2K | $18M | +2.77% |
| Q4 2024 | 109.6K | $16M | +2.09% |
| Q3 2024 | 58.1K | $9M | +2.19% |
| Q3 2023 | 1.4K | $221,321 | +0.12% |
| Q2 2023 | 6.1K | $1M | +0.51% |
| Q1 2023 | 6.1K | $945,810 | +0.51% |
| Q4 2022 | 14.8K | $3M | +1.71% |
| Q3 2022 | 15.2K | $2M | +1.71% |
| Q2 2022 | 16.3K | $3M | +1.77% |
| Q1 2022 | 24.0K | $4M | +1.42% |
| Q4 2021 | 16.5K | $3M | +1.39% |
| Q3 2021 | 16.5K | $3M | +1.32% |
| Q2 2021 | 10.8K | $2M | +0.90% |
| Q2 2019 | 7.8K | $1M | +0.89% |
| Q1 2019 | 8.7K | $1M | +0.94% |
| Q4 2018 | 8.3K | $1M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abacus Fcf Advisors LLC’s full portfolio or all institutional holders of JNJ.